Fibroblast growth factor 2-induced angiogenesis in zebrafish: The zebrafish yolk membrane (ZFYM) angiogenesis assay

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 2061-2068

  Nicoli, Stefania ^a,b   De Sena, Giulia ^a   Presta, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Angiogenesis; Embryo; FGF2; Inhibitors; Zebrafish

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ANGIOGENESIS; ANIMAL; ARTICLE; PHYSIOLOGY; VASCULARIZATION; YOLK SAC; ZEBRA FISH;

ANIMALS; FIBROBLAST GROWTH FACTOR 2; NEOVASCULARIZATION, PHYSIOLOGIC; YOLK SAC; ZEBRAFISH;

ANIMALIA; DANIO RERIO; SIMIAN IMMUNODEFICIENCY VIRUS; TELEOSTEI;

EID: 70449417554     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00432.x     Document Type: Article

References (39)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000 407 : 249 257.
2. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004 25 : 581 611. (Pubitemid 39099316)
3. Hasan J, Shnyder SD, Bibby M, et al. Quantitative angiogenesis assays in vivo - a review. Angiogenesis. 2004 7 : 1 16.
4. Lam SH, Wu YL, Vega VB, et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol. 2006 24 : 73 5.
5. Thisse C, Zon LI. Organogenesis-heart and blood formation from the zebrafish point of view. Science. 2002 295 : 457 462.
6. Weinstein B. Vascular cell biology in vivo: a new piscine paradigm Trends Cell Biol. 2002 12 : 439 445.
7. Nicoli S, Ribatti D, Cotelli F, et al. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res. 2007 67 : 2927 2931.
8. Nicoli S, Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc. 2007 2 : 2918 2923.
9. Haldi M, Ton C, Seng WL, et al. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis. 2006 9 : 139 151.
10. Stoletov K, Montel V, Lester RD, et al. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA. 2007 104 : 17406 17411.
11. Presta M, Moscatelli D, Joseph-Silverstein J, et al. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol. 1986 6 : 4060 4066.
12. Rusnati M, Presta M. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int J Clin Lab Res. 1996 26 : 15 23.
13. Presta M, Dell'Era P, Mitola S, et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005 16 : 159 178.
14. Nugent MA, Iozzo RV. Fibroblast growth factor-2. Int J Biochem Cell Biol. 2000 32 : 115 120.
15. Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res. 2000 60 : 4932 4938.
16. Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med. 1997 3 : 887 893.
17. Rusnati M, Presta M. Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des. 2007 13 : 2025 2044.
18. Isogai S, Horiguchi M, Weinstein BM. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev Biol. 2001 230 : 278 301.
19. Isacchi A, Statuto M, Chiesa R, et al. A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc Natl Acad Sci USA. 1991 88 : 2628 2632.
20. Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem. 1997 272 : 32817 32823.
21. Lawson ND, Vogel AM, Weinstein BM. sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell. 2002 3 : 127 136.
22. Cross LM, Cook MA, Lin S, et al. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol. 2003 23 : 911 912.
23. Westerfield M. The zebrafish book. Eugene, OR : University of Oregon Press 1995.
24. Serbedzija GN, Flynn E, Willett CE. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis. 1999 3 : 353 359.
25. Habeck H, Odenthal J, Walderich B, et al. Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Curr Biol. 2002 12 : 1405 1412.
26. Brown LA, Rodaway AR, Schilling TF, et al. Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos. Mech Dev. 2000 90 : 237 252.
27. Covassin L, Amigo JD, Suzuki K, et al. Global analysis of hematopoietic and vascular endothelial gene expression by tissue specific microarray profiling in zebrafish. Dev Biol. 2006 299 : 551 562.
28. Mohammadi M, McMahon G, Sun L, et al. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science. 1997 276 : 955 960.
29. Presta M, Camozzi M, Salvatori G, et al. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med. 2007 11 : 723 738.
30. Rusnati M, Camozzi M, Moroni E, et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood. 2004 104 : 92 9.
31. Nasevicius A, Larson J, Ekker SC. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast. 2000 17 : 294 301.
32. Pichler FB, Laurenson S, Williams LC, et al. Chemical discovery and global gene expression analysis in zebrafish. Nat Biotechnol. 2003 21 : 879 883.
33. Serbedzija GN, Flynn E, Willett CE. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis. 2000 3 : 353 359.
34. Molina GA, Watkins SC, Tsang M. Generation of FGF reporter transgenic zebrafish and their utility in chemical screens. BMC Dev Biol. 2007 7 : 62 75.
35. Fukino K, Sata M, Seko Y, et al. Genetic background influences therapeutic effectiveness of VEGF. Biochem Biophys Res Commun. 2003 310 : 143 147.
36. Zhu WH, Iurlaro M, MacIntyre A, et al. The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting. Angiogenesis. 2003 6 : 193 199.
37. Ribatti D, Nico B, Vacca A, et al. The gelatin sponge-chorioallantoic membrane assay. Nat Protoc. 2006 1 : 85 91.
38. Passaniti A, Taylor RM, Pili R, et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Investi. 1992 67 : 519 528.
39. Stabile H, Mitola S, Moroni E, et al. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood. 2007 109 : 1834 1840.